Esperion Therapeutics Acquired by ArchiMed | Healthcare M&A Deal

ArchiMed has acquired Esperion Therapeutics, a pharmaceuticals business in Michigan, for $3.16. Esperion Therapeutics develops prescription medicines and related therapies, supporting a pharmaceuticals acquisition strategy in Ann Arbor, MI. ArchiMed acquisitions in healthcare M&A focus on expanding a private equity acquisition portfolio through a merger acquisition of a public company. The merger acquisition is structured as a cash purchase plus one contractual contingent value right per share tied to milestone payments, with Esperion common stockholders voting at a virtual special meeting. The healthcare deals MI transaction is announced and follows an agreement and plan of merger with an ArchiMed affiliate, with deal completion subject to customary conditions.